Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Muraro

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Eclinicalmedicine|February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committeeRaffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Allergy|January 7, 2017
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysisU Nurmatov, S Dhami, S Arasi, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
BMJ Open|February 5, 2024
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trialGavin Brittain, Jennifer Petrie, Kate E M Duffy, et al.
Bone Marrow Transplantation|May 25, 2021
Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsRaffaella Greco, Tobias Alexander, Joachim Burman, et al.
JAMA Neurology|February 28, 2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisPaolo A Muraro, Marcelo Pasquini, Harold L Atkins, et al.
Allergy|January 30, 2018
EAACI Position paper on the standardization of nasal allergen challengesJ Augé, J Vent, I Agache, et al.
Allergy|June 10, 2014
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical ImmunologyA Muraro, G Roberts, M Worm, et al.
Allergy|May 4, 2016
Can we identify patients at risk of life-threatening allergic reactions to food?P J Turner, J L Baumert, K Beyer, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Brain : a Journal of Neurology|June 6, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunityTobias Ruck, Sumanta Barman, Andreas Schulte-Mecklenbeck, et al.
Eclinicalmedicine|February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committeeRaffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Allergy|January 7, 2017
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysisU Nurmatov, S Dhami, S Arasi, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
BMJ Open|February 5, 2024
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trialGavin Brittain, Jennifer Petrie, Kate E M Duffy, et al.
Bone Marrow Transplantation|May 25, 2021
Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsRaffaella Greco, Tobias Alexander, Joachim Burman, et al.
JAMA Neurology|February 28, 2017
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple SclerosisPaolo A Muraro, Marcelo Pasquini, Harold L Atkins, et al.
Allergy|January 30, 2018
EAACI Position paper on the standardization of nasal allergen challengesJ Augé, J Vent, I Agache, et al.
Allergy|June 10, 2014
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical ImmunologyA Muraro, G Roberts, M Worm, et al.
Allergy|May 4, 2016
Can we identify patients at risk of life-threatening allergic reactions to food?P J Turner, J L Baumert, K Beyer, et al.
Pageof 24